hydronephrosis is of unknown aetiology. Notley (1968) was able to show an increase in collagen infiltration in specimens excised during dismembered pyeloplasty, but it is not known whether these changes are primary, or secondary to preexisting obstruction. The lack of structural and pathological changes in the obstructed PUJ has led to the suggestion that the lesion in primary PUJ obstruction is principally physiological and therefore better treated by excision. Secondary PUJ obstruction occurs following surgical procedures attended by excessive fibrosis and cicatrization. Such pathology may be more amenable to treatment by incision, by analogy with other fibrotic strictures.
However, there is a group of elderly patients who present with PUJ obstruction without any antecedent surgery for hydronephrosis who are difficult to categorize. As exemplified by the present case, these patients respond to treatment by percutaneous pyelolysis and are in this respect more similar to patients with secondary PUJ obstruction.
We suggest that elderly patients presenting with PUJ obstruction, especially when complicated by general ill health or renal failure, may be more suitably treated by percutaneous pyelolysis and internal diversion than by conventional open surgery. Systemic amyloidosis is a rare cause of chronic renal failure and accounted for 1.3% of all new patients admitted to European renal replacement programmes in 1978. We report the first patient with renal amyloidosis to receive treatment with maintenance haemodialysis, continuous ambulatory peritoneal dialysis (CAPD) and cadaver renal transplantation.
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Case report
A 28-year-old man with bronchiectasis from childhood was referred for investigation of proteinuria. His creatinine clearance was 36 ml/minute and an intravenous pyelogram (IVP) was reported as chronic pyelonephritis with small kidneys. Repeated urine cultures failed to demonstrate significant pathogens. Urinary protein excretion of 7 g/day suggested a glomerular lesion but percutaneous renal biopsy was unsuccessful. His renal function deteriorated over a period of 4 years and he commenced chronic haemodialysis in July 1978. Vascular access was complicated by recurrent subcutaneous haemorrhage from arteriovenous fistulae and eventually a Goretex graft was inserted in his leg.
In December 1978 he received a cadaver renal transplant which resulted in normal renal function. After 2 years, however, his creatinine clearance had fallen to 20 ml/minute. A needle biopsy of the transplanted kidney suggested an interstitial nephritis from a viral infection and polyoma virus was found in the urine. There was no proteinuria. Three years after transplantation graft function had further deteriorated and he was started on CAPD in October 1981. Graft nephrectomy was not performed. Long-term ampicillin was necessary to reduce purulent sputum from his bronchiectasis but despite this he experienced 7 episodes of peritonitis in 18 months on CAPD. After repeated attempts, it proved impossible to completely withdraw the corticosteroids given as part of the immunosuppressive regimen for his transplant. A Synacthen test showed absent adrenal cortical function. He died following an episode of acute pancreatitis.
At necropsy amyloidosis was an unexpected finding and histology confirmed widespread systemic deposition of secondary (AA) amyloid protein. The adrenal glands were enlarged and extensively replaced by amyloid and there were bronchiectatic changes in both lungs. His original kidneys were small, firm and waxy. Using a quantitative assessment (Tribe et al. 1983 ), 78% of the area of a random sample of glomeruli was found to be replaced by amyloid protein. Previous biopsies were then re-examined in order to estimate the rate of amyloid involvement in the transplanted kidney. A section of renal cortex taken at the time of transplant was free of amyloid. The needle biopsy obtained 2 years later contained amyloid, but only 1% of glomerular area was involved. At necropsy, 4-* years after transplantation, an estimated 7% of the glomerular area of the kidney graft was infiltrated by amyloid protein (Figure 1 ).
Discussion
It is probable that the original cause of renal failure in our patient was renal amyloidosis, secondary to bronchiectasis. Amyloid infiltration of the adrenals had resulted in the need for steroid replacement. Severe adrenal involvement is found at necropsy in up to 20% of patients with secondary amyloidosis but clinical evidence of Addison's disease is rare (Stemmerman & Auerback 1944) . In our patient, dependence on corticosteroids probably resulted from the continuing deposition of amyloid protein in the adrenal glands during his 5 years of extended survival by renal replacement therapy.
Haemodialysis (Jones 1976) , CAPD (Browning et al. 1984) and transplantation (Jones 1976 , Kuhlback et al. 1979 ), have all been described in the treatment of end-stage renal amyloidosis, but never before in a single patient. Our case illustrates many of the problems encountered in the management of these cases. For example, maintenance haemodialysis may be complicated by problems of vascular access resulting from deposition of amyloid protein in large vessels. Our experience of CAPD in this condition has been good (Browning et al. 1984) , but in the present patient persistence of purulent sputum predisposed to frequent infections of his indwelling cannula and thus to peritonitis. Infiltration of the allograft by amyloid has been reported after renal transplantation (Kuhlback et al. 1979 ) but the present case indicates that the process is slow. Glomerular involvement in the graft, absent at the time of transplantation, had reached only. 1% at 2 years and 7% at 4 years and did not limit graft survival. As systemic reactive (AA) amyloidosis seldom involves major organs other than the kidney, patients with chronic renal failure and secondary amyloidosis should not be denied the chance of renal transplantation.
